Event Date/Time: Oct 16, 2007
End Date/Time: Oct 17, 2007
Clinical trial safety and post marketing pharmacovigilance constitute a risk management continuum, in which a pharmaceutical’s benefit/risk balance is monitored and re-evaluated on an ongoing basis. A major aspect of this critical public health function is performance of high quality medical assessment of adverse drug events in both pre- and post marketing realms. For that new to pharmaceutical safety, it is imperative to become familiar with regulatory requirements and initiatives, both US and international, which form the basis for compliance standards. In this conference, a range of topics relating to pre marketing clinical trials and post marketing pharmacovigilance will be addressed, providing attendees with an overview of the various activities performed by safety specialists.